(Q48171302)

9 February 2018

title

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. (English)

1 reference

9 February 2018

author name string

Xue D

1

1 reference

9 February 2018

Huang ZG

2

1 reference

9 February 2018

Barnes K

3

1 reference

9 February 2018

Lesiuk HJ

4

1 reference

9 February 2018

Smith KE

5

1 reference

9 February 2018

Buchan AM

6

1 reference

9 February 2018

publication date

1 March 1994

1 reference

9 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

9 February 2018

volume

14

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

251-261

1 reference

9 February 2018

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

A new model of temporary focal neocortical ischemia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Calcium-permeable AMPA-kainate receptors in fusiform cerebellar glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Glutamate neurotoxicity in cortical cell culture is calcium dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Permeation of Calcium Ions Through Non-NMDA Glutamate Channels in Retinal Bipolar Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Identification of a site in glutamate receptor subunits that controls calcium permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Neuroprotective effects of glutamate antagonists and extracellular acidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Non-NMDA receptor mediates cytoplasmic Ca2+ elevation in cultured hippocampal neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

RNA editing in brain controls a determinant of ion flow in glutamate-gated channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Structural determinants of ion flow through recombinant glutamate receptor channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

Failure of MK-801 to reduce infarct volume in thrombotic middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

GYKI 52466 blocks the increase in extracellular glutamate induced by ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

Focal Brain Ischemia in the Rat: Methods for Reproducible Neocortical Infarction Using Tandem Occlusion of the Distal Middle Cerebral and Ipsilateral Common Carotid Arteries

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

Middle cerebral artery occlusion in the young rat

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

The expression of a cerebellar degeneration‐associated neural antigen in human tumor line cells

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1994.32

7 January 2021

Identifiers

DOI

10.1038/JCBFM.1994.32

1 reference

9 February 2018

PubMed ID

7509339

1 reference

9 February 2018